FDA raised scientific and regulatory objections, but critics have pointed to the strong opposition from some social conservatives and antiabortionist

Plan B Battles Embroil States: "By Marc Kaufman | Washington Post Staff Writer | Monday, February 27, 2006; Page A01

Proposals Mirror Red-Blue Divide

Filling a void left by the Food and Drug Administration's inability to decide whether to make the 'morning-after' pill available without a prescription, nearly every state is or soon will be wrestling with legislation that would expand or restrict access to the drug.
...
But some bills would make it more difficult for many women to get emergency contraception, which is effective for only 72 hours after a woman experiences a contraceptive failure or unprotected sex. ...
...
But the FDA leadership first rejected and then deferred decision on the proposal. The agency has raised scientific and regulatory objections, but critics have pointed to the strong opposition from some social conservatives and antiabortion groups, who have lobbied the White House and Congress to make their position known. Plan B is officially listed as a contraceptive, and the medical community generally agrees that it stops a pregnancy from occurring rather than ending one. But many in the antiabortion movement disagree with that view and say that it amounts to a very early abortion.

The FDA's inaction on Plan B has been sharply criticized by most major medical societies and many in Congress, and led to a lawsuit by the Center for Reproductive Rights in New York. The federal magistrate judge hearing the case on Friday concluded that the center had established a "strong preliminary showing of 'bad faith or misbehavior' " on the part of FDA officials, and so ordered the case to go forward and ruled that top current and past FDA leaders should be interviewed under oath. ...